Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Empasiprubart (ARGX-117) is a humanized inhibitory monoclonal antibody targeting complement C2. It inhibits the formation of C3 proconvertase, obstructing classical and lectin pathway activation by binding to the Sushi-2 domain of C2 upstream of C3. The binding of Empasiprubart is pH- and calcium-dependent. The compound demonstrates efficacy in preventing complement-mediated cytotoxicity within in vitro models of autoimmune hemolytic anemia and antibody-mediated organ transplant rejection [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | Inquiry | Inquiry | |
5 mg | Inquiry | Inquiry |
Description | Empasiprubart (ARGX-117) is a humanized inhibitory monoclonal antibody targeting complement C2. It inhibits the formation of C3 proconvertase, obstructing classical and lectin pathway activation by binding to the Sushi-2 domain of C2 upstream of C3. The binding of Empasiprubart is pH- and calcium-dependent. The compound demonstrates efficacy in preventing complement-mediated cytotoxicity within in vitro models of autoimmune hemolytic anemia and antibody-mediated organ transplant rejection [1]. |
Synonyms | ARGX-117 |
Molecular Weight | N/A |
CAS No. | 2579031-19-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Empasiprubart 2579031-19-7 ARGX-117 inhibitor inhibit